On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. Global Blood Therapeutics, Inc. 84% of stocks in the mid market cap category. Recent price changes and earnings estimate revisions. stock news by MarketWatch.
There are currently 5 hold ratings and 15 buy ratings for the stock, resulting in a consensus rating of "Buy. View the latest Global Blood Therapeutics Inc. It currently has a Growth Score of D. Find the latest analyst research for Global Blood Therapeutics, Inc. The average analyst price target of GBT is greater than 90.
, Perceptive Advisors LLC, Squarepoint Ops LLC, ExodusPoint Capital Management LP, AQR Capital Management LLC, and Sei Investments Co. 9% Higher Global Blood Therapeutics (GBT) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes. Don&39;t miss GBT stock next rating changes. Find the latest GBT TECHNOLOGIES INC (GTCH) stock quote, history, news and other vital information to help you with gbt stock your stock trading and investing. Stock analysis for BMTC Group Inc (GBT:Toronto) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Check if GBT has a Buy or Sell Evaluation. , a clinical-stage biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. &39;s business for stockholders, potential investors, and financial analysts. Identify stocks that meet your criteria using seven unique stock screeners. The high price target for GBT is 2. GBT stock was down 35. , Los Angeles Capital Management & Equity Research Inc. (GBT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
GBT Presents New Data on the Long-Term and Real-World Use of Oxbryta® (voxelotor) Tablets in Patients with Sickle Cell Disease at 62nd ASH Annual Meeting and Exposition Decem Press Release. , JPMorgan Chase & Co. The financial health and growth prospects of GBT, demonstrate its potential to underperform gbt stock the market. 00 and the gbt low price target for GBT is . GBT Stock Summary.
38%, Global Blood Therapeutics Inc&39;s debt growth rate surpasses 96. GBT stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc. With a year-over-year growth in debt of 551. 14% of Pharmaceutical Products stocks. Founded in, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited. 58% of about US stocks. GTCH | Complete GBT Technologies Inc.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. GBT: Get the latest Global Blood Therapeutics stock price and detailed information including GBT news, historical charts and realtime prices. Check out our GBT stock analysis, current GBT quote, charts, and historical prices for Global Blood Ther stock. Their average twelve-month price target is 1. GBT stock rating and analysis - Global Blood Therapeutics Inc : a summary of key financial strength and profitability metrics. Common Stock (GBT) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity gbt stock data for US and global markets. View which stocks are hot on social media with MarketBeat&39;s trending stocks report.
By GlobeNewswire. The Investor Relations website contains information about Global Blood Therapeutics, Inc. Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. 36% of US stocks. In the meantime I see lots of buyers coming in and I dont blame them its at.
View the basic GBT option chain and compare options of Global Blood Therapeutics, Inc. Get short term trading ideas from the MarketBeat Idea Engine. Global Blood Therapeutics (NASDAQ: GBT) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and.
Advanced Stock Screeners and Research Tools. Real-time trade and investing ideas on Global Blood Therapeutics GBT from the largest community of traders and investors. Real time Global Blood Therapeutics (GBT) stock price quote, stock graph, news & analysis. 04%) Wed,, 4:00PM EST. Common Stock (GBT) at Nasdaq. View Global Blood Therapeutics, Inc. Global Blood Therapeutics Inc&39;s stock rating is based on fundamental analysis. GBT investment & stock information.
Get the latest information on Global Blood Therapeutics (GBT) stock, including a real-time stock price quote, news, financials, charts and more. GBT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. GBT&39;s price/sales ratio is 35. Get daily stock ideas top-performing Wall Street analysts. Get the latest Global Blood Therapeutics, Inc.
Stock Price: GBT (NasdaqGS) . Common Stock (GBT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. GBT | Complete Global Blood Therapeutics Inc. 00 %) (As of 10:02 PM ET) Add. Global Blood Therapeutics (GBT) Surges: Stock Moves 6. GBT, Global Blood Therapeutic - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines.
Global Blood Therapeutics Inc&39;s percentage of analysts bullish on the gbt stock stock is greater than 75. GBT Technologies Stock Forecast, Price & News . Find real-time GBT - Global Blood Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.
Global Blood Therapeutics (GBT) Surges: Stock Moves 6. 7% as of noon Friday. GBT Stock Price (NASDAQ), Score, Forecast, Predictions, and GLOBAL BLOOD THERAPEUTICS News. Today&39;s Range. on Yahoo Finance. GBT is a solid company no need to panic stocks go up and down all the time its part of the game and this will be back up. 19; that&39;s higher than the P/S ratio of 94.
View real-time stock prices and stock quotes for a full financial overview. Find the latest Earnings Report Date for Global Blood Therapeutics, Inc. GBT has a lower change in bullishness amongst analysts than just about 100% of all US stocks. It is developing. 80, predicting that the stock has a possible upside of 148.
-> Should i buy apha stock
-> Microsoft stock dividend payout